Florida sues Pfizer and its chief executive over COVID-19 vaccine marketing
Florida Attorney General James Uthmeier sued Pfizer and Chairman and Chief Executive Albert Bourla on October 1, 2026, accusing them of deceptive promotion of the company's COVID-19 vaccine. The state alleges Pfizer misstated vaccine safety and its effect on transmission while failing to disclose certain risks. The complaint seeks injunctions, profit recovery and civil penalties; Pfizer says its vaccine statements were accurate, supported by science, and that the claims lack merit.
Why it matters
The case could expose Pfizer to state-law penalties, restitution and limits on future marketing if Florida prevails. Pfizer says it will defend its vaccine's safety and effectiveness and respond through the legal process.
Key facts
- 1Florida Attorney General James Uthmeier brought the civil case against Pfizer and Albert Bourla on October 1, 2026. tampafp.com
- 2The complaint was lodged in a St. Lucie County state court and alleges violations of the Florida Deceptive and Unfair Trade Practices Act. tampafp.com
- 3Florida seeks permanent injunctive relief, profit disgorgement and civil fines of up to $10,000 per violation, with $15,000 available for violations involving seniors or people with disabilities. tampafp.com
- 4Pfizer said its vaccine representations were accurate and science-based and described Florida's allegations as lacking merit. cltampa.com
- 5A Florida statewide grand jury reported in January 2025 that it found no evidence that COVID-19 vaccine makers had violated federal or state law in producing and distributing vaccines. cltampa.com
Open questions
- The ultimate legal outcome, any damages or penalties, and the timing of a court decision are not provided.
- The alleged vaccine-revenue figures differ across materials: some describe more than $80 billion, while another reports $85.81 billion for 2021 to 2023.
Summary written by AlphAI from 11 of 11 sources. Not investment advice. Figures are as stated by the linked sources.